At a glance
Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required) is a federal competitive grant from National Institutes of Health for the science & technology sector. Funding is up to $700K. Eligible applicants: City or township governments; Special district governments; Independent school districts; State governments; Native American tribal governments (Federally recognized); Native American tribal organizations (other than Fed. The application deadline is October 1, 2026. Apply via the official listing at www.grants.gov.
- Amount
- Up to $700K
- Deadline
- Oct 1, 2026
- Type
- Competitive
- Status
- Closing soon
About this program
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for research on novel therapies for adult glioblastoma (GBM). The goal is to improve the treatment of adult GBM by developing novel effective agents that can cross the blood brain barrier (BBB) and testing them clinically. Successful early-stage trials of new drugs from this NOFO would transition seamlessly to later stage trials using well-established NCI clinical trial mechanisms.To implement this concept, a highly collaborative GBM Therapeutics Network (GTN) of cross-cutting teams will be established, each team capable of driving therapeutic agent(s) from pre-clinical development, through investigational new drugs (IND) studies, into pilot clinical studies in humans. Appropriate therapeutic agents include: (1) novel agents or (2) agents or combinations approved for other indications and repurposed for treatment of GBM following appropriate preclinical studies. The scope of the NOFO, from late pre-clinical through early (Phase 0/1) clinical studies, uniquely spans a gap in the GBM drug development process.
Who can apply
City or township governments; Special district governments; Independent school districts; State governments; Native American tribal governments (Federally recognized); Native American tribal organizations (other than Federally recognized tribal governments); Small businesses; County governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Private institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); For profit organizations other than small businesses; Public and State controlled institutions of higher education; Public housing authorities/Indian housing authorities. Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
How to apply
Apply through Grants.gov using funding opportunity number RFA-CA-27-005. Register your organization (SAM.gov + Grants.gov) before the deadline, then submit the application package listed in the official notice.
Apply at official sourceRelated grants
- F26AS00030 Cooperative Endangered Species Conservation Fund: Recovery Land Acquisition Grant Program DOI · $10K–$14.2M · Nov 20, 2026 Open
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) NIH · See listing · Sep 7, 2027 Open
- Continuation or Revision of NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UH3 Clinical Trial Required) NIH · See listing · Jan 6, 2028 Open
- Cannabis Research and Innovation Funding Opportunity (RIFO) Department of Fish and Wildlife · Dependant on number of submissions received, application process, etc. · Rolling Open